LaForce C[au] - Search Results

Year	Number of Results
1981	1
1983	1
1984	1
1990	2
1991	1
1992	1
1993	1
1994	3
1996	4
1997	1
1998	3
1999	4
2000	2
2001	1
2002	1
2003	3
2004	1
2005	6
2006	3
2007	2
2008	5
2009	5
2010	5
2011	7
2012	5
2013	3
2014	6
2015	1
2016	1
2017	4
2018	1
2019	2
2021	2
2022	1

1

Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.

Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, Lugogo N, Wenzel S, Chinchilli VM, Mauger DT, Dyer AM, Boushey HA, Fahy JV, Woodruff PG, Bacharier LB, Cabana MD, Cardet JC, Castro M, Chmiel J, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Hastie A, Holguin F, Israel E, Jackson D, Kraft M, LaForce C, Lemanske RF Jr, Martinez FD, Moore W, Morgan WJ, Moy JN, Myers R, Peters SP, Phipatanakul W, Pongracic JA, Que L, Ross K, Smith L, Szefler SJ, Wechsler ME, Sorkness CA; National Heart, Lung, and Blood Institute AsthmaNet. Lazarus SC, et al. Among authors: laforce c. N Engl J Med. 2019 May 23;380(21):2009-2019. doi: 10.1056/NEJMoa1814917. Epub 2019 May 19. N Engl J Med. 2019. PMID: 31112384 Free PMC article. Clinical Trial.

2

Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis.

Nayak AS, Berger WE, LaForce CF, Urdaneta ER, Patel MK, Franklin KB, Wu MM. Nayak AS, et al. Among authors: laforce cf. Allergy Asthma Proc. 2017 May 1;38(3):222-230. doi: 10.2500/aap.2017.38.4050. Allergy Asthma Proc. 2017. PMID: 28441993 Clinical Trial.

3

Use of nasal steroids in managing allergic rhinitis.

LaForce C. LaForce C. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 2):S388-94. doi: 10.1016/s0091-6749(99)70218-6. J Allergy Clin Immunol. 1999. PMID: 10069899 Review.

4

Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.

Cappelletti C, Maes A, Rossman K, Gillen M, LaForce C, Kerwin EM, Reisner C. Cappelletti C, et al. Among authors: laforce c. Clin Drug Investig. 2021 Jun;41(6):579-590. doi: 10.1007/s40261-021-01040-7. Epub 2021 Jun 4. Clin Drug Investig. 2021. PMID: 34089147 Free PMC article. Clinical Trial.

5

Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.

Vogelmeier C, Magnussen H, LaForce C, Owen R, Kramer B. Vogelmeier C, et al. Among authors: laforce c. Ther Adv Respir Dis. 2011 Oct;5(5):345-57. doi: 10.1177/1753465811410100. Epub 2011 Jun 30. Ther Adv Respir Dis. 2011. PMID: 21719531 Free article. Review.

6

Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma.

Wechsler ME, Szefler SJ, Ortega VE, Pongracic JA, Chinchilli V, Lima JJ, Krishnan JA, Kunselman SJ, Mauger D, Bleecker ER, Bacharier LB, Beigelman A, Benson M, Blake KV, Cabana MD, Cardet JC, Castro M, Chmiel JF, Covar R, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Grossman N, Holguin F, Jackson DJ, Kumar H, Kraft M, LaForce CF, Lang J, Lazarus SC, Lemanske RF Jr, Long D, Lugogo N, Martinez F, Meyers DA, Moore WC, Moy J, Naureckas E, Olin JT, Peters SP, Phipatanakul W, Que L, Raissy H, Robison RG, Ross K, Sheehan W, Smith LJ, Solway J, Sorkness CA, Sullivan-Vedder L, Wenzel S, White S, Israel E; NHLBI AsthmaNet. Wechsler ME, et al. Among authors: laforce cf. N Engl J Med. 2019 Sep 26;381(13):1227-1239. doi: 10.1056/NEJMoa1905560. N Engl J Med. 2019. PMID: 31553835 Free PMC article. Clinical Trial.

7

Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE study.

LaForce C, Chipps BE, Albers FC, Reilly L, Johnsson E, Andrews H, Cappelletti C, Maes A, Papi A. LaForce C, et al. Ann Allergy Asthma Immunol. 2022 Feb;128(2):169-177. doi: 10.1016/j.anai.2021.10.020. Epub 2021 Oct 24. Ann Allergy Asthma Immunol. 2022. PMID: 34699967 Clinical Trial.

8

Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function.

Meltzer EO, Kuna P, Nolte H, Nayak AS, Laforce C; P04073 Study Investigators. Meltzer EO, et al. Among authors: laforce c. Eur Respir J. 2012 Feb;39(2):279-89. doi: 10.1183/09031936.00020310. Epub 2011 Aug 4. Eur Respir J. 2012. PMID: 21828036 Free article. Clinical Trial.

9

Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma.

LaForce C, Taveras H, Iverson H, Shore P. LaForce C, et al. Allergy Asthma Proc. 2017 Jan 28;38(1):28-37. doi: 10.2500/aap.2017.38.4015. Allergy Asthma Proc. 2017. PMID: 28052799 Clinical Trial.

10

Long-term safety of tiotropium/olodaterol Respimat^® in patients with moderate-to-very severe COPD and renal impairment in the TONADO^® studies.

LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R. LaForce C, et al. Int J Chron Obstruct Pulmon Dis. 2018 Jun 1;13:1819-1831. doi: 10.2147/COPD.S161489. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29910611 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results